2-naphthol has been researched along with Hodgkin Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bach, EA; Baeg, GH; Jayabose, S; Kim, BH; Kim, EA; Kim, MS; Lee, HK; Lee, S; Oh, SR; Sandoval, C; Yin, CH | 1 |
| Iijima, S; Itagaki, T; Nanba, K | 1 |
2 other study(ies) available for 2-naphthol and Hodgkin Disease
| Article | Year |
|---|---|
MS-1020 is a novel small molecule that selectively inhibits JAK3 activity.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drosophila; Drug Screening Assays, Antitumor; Hodgkin Disease; Humans; Interleukin-2; Janus Kinase 3; Naphthols; Plant Extracts; Protein Kinase Inhibitors; Rats; Serotonin; Signal Transduction; STAT Transcription Factors; STAT3 Transcription Factor; T-Lymphocytes; Tumor Cells, Cultured | 2010 |
Enzyme histochemical investigations of human malignant lymphomas.
Topics: Acid Phosphatase; Esterases; Glucuronidase; Histocytochemistry; Hodgkin Disease; Humans; Hyperplasia; Isoenzymes; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma; Naphthols | 1975 |